Flexible-dose Long-term Extension Study of Lu AF11167 in Patients With Schizophrenia With Prominent Negative Symptoms
Status:
Terminated
Trial end date:
2020-09-14
Target enrollment:
Participant gender:
Summary
A study to evaluate the long-term safety and tolerability of flexible doses of Lu AF11167 in
patients with schizophrenia during the 24-week treatment period